← All stocks

UroGen Pharma Ltd.

URGN Net selling
CIK 0001668243 #1945 in the set updated 17 Sep 2026
Bought (120 mo)
$791.52K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$15.54M
$1.30M on a plan · $1.46M straight out of an exercise
Sold at will
$12.77M
31 of 94 sales
Net
−$14.74M
−$11.98M against sales at will

By person

17 insiders · 114 transactions
16.2×

Elizabeth Barrett holds 16.2 times base salary in stock. $13.90M of shares against $855.59K in salary for 2025.

Salary from the company's own proxy. The shares are what Elizabeth Barrett last reported holding, valued at $42.54, the price Ordinary Shares was last bought or sold at on the open market here, on 8 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
ProQuest Investments IV, L.P. entity
10% owner
$8.50M (2)
−$8.50M
1,242,031
$52.84M
−14.4%
Schoenberg Mark
Chief Medical Officer
$67.38K (3)
$5.38M (49)
−$5.31M
67,849
$2.89M
+217.5%
Smith Jason Drew
General Counsel
$39.28K (1)
$725.47K (19) scheduled
−$686.19K
53,141
$2.26M
Mullennix Stephen
Chief Operating Officer
$203.44K (7) scheduled
−$203.44K
10,084
$428.97K
PFREUNDSCHUH PETER P.
Chief Financial Officer
$166.69K (11) scheduled
−$166.69K
10,405
$442.63K
+940.5%
Barrett Elizabeth A.
Chief Executive Officer
$645.25K (4)
$491.88K (3)
+$153.37K
326,691
$13.90M
Degnan Chris
Chief Financial Officer
$37.12K (1) scheduled
−$37.12K
2,280
$96.99K
Henderson Molly
Chief Financial Officer
$39.63K (1)
$33.63K (2) scheduled
+$5.99K
5,248
$223.25K
Nussbaum Ran
Director
4,381,054
$186.37M
+1.3%
Belldegrun Arie
Director
408,693
$17.39M
+257.8%
Cohen Fred E
Director
84,339
$3.59M
Kim Dong
Chief Financial Officer
37,753
$1.61M
+18.3%
Robinson James A. Jr.
Director
8,000
$340.32K
WEN LEANA
Director
2,000
$85.08K
Wildman Daniel George
Director
2,000
$85.08K
Holden Stuart
Director
2,000
$85.08K
BUTITTA CYNTHIA M
Director
2,000
$85.08K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
Schoenberg Mark
8 Jun 2026
Chief Medical Officer
Sold after exercise
5,222
$27.30
$142.56K
Degnan Chris
8 Oct 2025
Chief Financial Officer
Sold after exercise
2,203
$16.85
$37.12K
Schoenberg Mark
28 Jul 2025
Chief Medical Officer
Sold after exercise
5,149
$19.14
$98.55K
Smith Jason Drew
28 Jul 2025
General Counsel
Sold after exercise
7,522
$19.14
$143.97K
Smith Jason Drew
31 Jan 2025
General Counsel
Sold after exercise
2,767
$11.14
$30.82K
Smith Jason Drew
31 Jan 2025
General Counsel
Sold after exercise
3,354
$11.14
$37.36K
Smith Jason Drew
31 Jan 2025
General Counsel
Sold after exercise
1,258
$11.14
$14.01K
Schoenberg Mark
31 Jan 2025
Chief Medical Officer
Sold after exercise
1,896
$11.14
$21.12K
Schoenberg Mark
31 Jan 2025
Chief Medical Officer
Sold after exercise
1,896
$11.14
$21.12K
Schoenberg Mark
31 Jan 2025
Chief Medical Officer
Sold after exercise
759
$11.14
$8.46K
Smith Jason Drew
9 Sep 2024
General Counsel
Sold after exercise
1,521
$13.08
$19.89K
Schoenberg Mark
9 Sep 2024
Chief Medical Officer
Sold after exercise
859
$13.08
$11.24K
Schoenberg Mark
10 Jun 2024
Chief Medical Officer
Sold after exercise
5,153
$13.08
$67.40K
Schoenberg Mark
31 Jan 2024
Chief Medical Officer
Sold after exercise
1,894
$15.74
$29.81K
Schoenberg Mark
31 Jan 2024
Chief Medical Officer
Sold after exercise
758
$15.74
$11.93K
Schoenberg Mark
31 Jan 2024
Chief Medical Officer
Sold after exercise
1,137
$15.74
$17.90K
Smith Jason Drew
31 Jan 2024
General Counsel
Sold after exercise
3,328
$15.74
$52.38K
Smith Jason Drew
31 Jan 2024
General Counsel
Sold after exercise
1,248
$15.74
$19.64K
Smith Jason Drew
31 Jan 2024
General Counsel
Sold after exercise
417
$15.74
$6.56K
Smith Jason Drew
31 Aug 2023
General Counsel
Sold after exercise
3,800
$18.01
$68.44K
Schoenberg Mark
31 Jan 2023
Chief Medical Officer
Sold after exercise
661
$10.12
$6.69K
Schoenberg Mark
31 Jan 2023
Chief Medical Officer
Sold after exercise
991
$10.12
$10.03K
Schoenberg Mark
31 Jan 2023
Chief Medical Officer
Sold after exercise
248
$10.12
$2.51K
Smith Jason Drew
31 Jan 2023
General Counsel
Sold after exercise
1,227
$10.12
$12.42K
Smith Jason Drew
31 Jan 2023
General Counsel
Sold after exercise
409
$10.12
$4.14K
Schoenberg Mark
31 Oct 2022
Chief Medical Officer
Sold after exercise
258
$11.85
$3.06K
Smith Jason Drew
31 Aug 2022
General Counsel
Sold after exercise
3,606
$7.21
$26.00K
Schoenberg Mark
30 Apr 2022
Chief Medical Officer
Sold after exercise
254
$6.62
$1.68K
Barrett Elizabeth A.
31 Jan 2022
Chief Executive Officer
Sold after exercise
5,960
$7.58
$45.18K
Barrett Elizabeth A.
31 Jan 2022
Chief Executive Officer
Sold after exercise
2,235
$7.58
$16.94K
Schoenberg Mark
31 Jan 2022
Chief Medical Officer
Sold after exercise
1,099
$7.58
$8.33K
Schoenberg Mark
31 Jan 2022
Chief Medical Officer
Sold after exercise
275
$7.58
$2.08K
Henderson Molly
31 Jan 2022
Chief Financial Officer
Sold after exercise
331
$7.58
$2.51K
Smith Jason Drew
31 Jan 2022
General Counsel
Sold after exercise
414
$7.58
$3.14K
Schoenberg Mark
26 Jan 2022
Chief Medical Officer
Sold after exercise
111
$8.09
$897.99
Henderson Molly
30 Nov 2021
Chief Financial Officer
Sold after exercise
2,587
$12.03
$31.12K
Smith Jason Drew
30 Nov 2021
General Counsel
Sold after exercise
3,803
$12.03
$45.75K
Schoenberg Mark
26 Jul 2021
Chief Medical Officer
Sold after exercise
103
$15.30
$1.58K
Schoenberg Mark
30 Apr 2021
Chief Medical Officer
Sold after exercise
243
$20.00
$4.86K
Schoenberg Mark
26 Apr 2021
Chief Medical Officer
Sold after exercise
89
$19.63
$1.75K
Schoenberg Mark
31 Jan 2021
Chief Medical Officer
Sold after exercise
1,076
$22.07
$23.75K
Schoenberg Mark
26 Jan 2021
Chief Medical Officer
Sold after exercise
100
$22.12
$2.21K
Schoenberg Mark
4 Dec 2020
Chief Medical Officer
Sold after exercise
662
$19.85
$13.14K
Schoenberg Mark
26 Oct 2020
Chief Medical Officer
Sold after exercise
101
$20.95
$2.12K
PFREUNDSCHUH PETER P.
15 Oct 2020
Chief Financial Officer
Sold after exercise
1,017
$21.72
$22.09K
PFREUNDSCHUH PETER P.
15 Oct 2020
Chief Financial Officer
Sold after exercise
407
$21.82
$8.88K
PFREUNDSCHUH PETER P.
15 Oct 2020
Chief Financial Officer
Sold after exercise
976
$21.80
$21.28K
Schoenberg Mark
4 Sep 2020
Chief Medical Officer
Sold after exercise
348
$20.20
$7.03K
PFREUNDSCHUH PETER P.
1 Sep 2020
Chief Financial Officer
Sold after exercise
509
$22.82
$11.62K
Schoenberg Mark
4 Jun 2020
Chief Medical Officer
Sold after exercise
349
$27.51
$9.60K
PFREUNDSCHUH PETER P.
20 May 2020
Chief Financial Officer
Sold after exercise
358
$25.07
$8.98K
PFREUNDSCHUH PETER P.
20 Feb 2020
Chief Financial Officer
Sold after exercise
360
$29.68
$10.68K
Mullennix Stephen
14 Feb 2020
Chief Operating Officer
Sold after exercise
612
$28.04
$17.16K
PFREUNDSCHUH PETER P.
20 Nov 2019
Chief Financial Officer
Sold after exercise
354
$28.41
$10.06K
Mullennix Stephen
14 Nov 2019
Chief Operating Officer
Sold after exercise
608
$26.00
$15.81K
Schoenberg Mark
4 Sep 2019
Chief Medical Officer
Sold after exercise
343
$33.92
$11.63K
PFREUNDSCHUH PETER P.
20 Aug 2019
Chief Financial Officer
Sold after exercise
1,416
$33.07
$46.83K
Mullennix Stephen
14 May 2019
Chief Operating Officer
Sold after exercise
608
$37.98
$23.09K
Mullennix Stephen
14 Feb 2019
Chief Operating Officer
Sold after exercise
2,804
$37.30
$104.59K

What was left out

Form 4 filings counted 195
Amendments (4/A) skipped 12
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 59
Sales at will 31
Transactions with no price 0
Shares from compensation/vesting 1,174,051
Sales filed before the plan box existed 17
History held since 29 Nov 2017